Tonix Pharma (TNXP) Tops Q4 EPS by 46c

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($0.56), $0.46 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• SEI Investments (SEIC) PT Raised to $115 at Morgan Stanley